Stay updated on Efruxifermin in NASH Subjects Clinical Trial
Sign up to get notified when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.

Latest updates to the Efruxifermin in NASH Subjects Clinical Trial page
- ChecktodayChange DetectedAdded a MedlinePlus Genetics topic: Non-alcoholic fatty liver disease and updated the page to v3.0.2; removed the old revision tag (v3.0.1) and the Back to Top link.SummaryDifference0.5%
- Check8 days agoChange DetectedThe page has been updated to version 3.0.1, and the topic on non-alcoholic fatty liver disease has been removed.SummaryDifference0.5%
- Check15 days agoChange DetectedThe web page has been updated to include new facility and location information, as well as recent research references related to Fatty Liver Disease and drug safety. Notably, the previous location details have been removed.SummaryDifference6%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated to version v2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Efruxifermin in NASH Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.